of course its for real. immuno oncology is THE most promising field of development to cure cancer. EVERY key opinion leader in the oncology field is talking about it. And imugene are at the forefront of progressing real therapeutics that are passing major hurdles. If this was a US company it would be valued at many multiples. The likely end game for Imugene is that it will be swallowed by US pharma. At least holders win in any case. I wish there were more appetite for supporting companies like this in Australia but I guess we win as holders anyway. hold on tight, the pipeline is advancing nicely right now. as much as I hate it, I would like a US pharma to pick this up so the products advance quickly to help people. we win big as holders anyway. maybe not as big as we could but no one will be unhappy.
Ann: Imugene Receives FDA IND Approval for PD1-VAXX Trial in USA, page-69
-
- There are more pages in this discussion • 69 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $382.1M | |||
| Open | High | Low | Value | Volume |
| 5.3¢ | 5.3¢ | 5.2¢ | $160.0K | 3.048M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 882045 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 457736 | 5 |
View Market Depth
| Last trade - 16.10pm 19/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |